Skip to main content

Advertisement

SpringerLink
Log in

Uncommon Late Relapse of Angioimmunoblastic T-Cell Lymphoma after 16-Year Remission Period

  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

AITL:

Angioimmunoblastic T-cell lymphoma

EBV:

Epstein-Barr virus

18FDG-PET/CT:

18Fluoro-deoxy-glucose Positron Emission Tomography/Computed Tomography

LDH:

Lactate dehydrogenase

CHOP:

Cyclophosphamide, doxorubicine, vincristine, prednisone

COPBLAM:

Cyclophosphamide, vincristine, prednisone, bleomycin, adriamycin and procarbazin

CEVP:

Cyclophosphamide, vinblastine, epirubicin and prednisone

DHAP:

Dexamethasone, cytarabin, and cisplatin

TNF:

Tumor necrosis factor

EBER:

Epstein-Barr early RNA

References

  1. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non- Hodgkin’s lymphoma: the Non-Hodgkin’s Lymphoma Classification Project. Blood 89: 3909–3918

  2. Mourad N, Mounier N, Brière J, Raffoux E, Delmer A, Feller A, Meijer CJ, Emile JF, Bouabdallah R, Bosly A, Diebold J, Haioun C, Coiffier B, Gisselbrecht C, Gaulard P (2008) Groupe d'Etude des Lymphomes de l'Adulte: clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 1;111(9): 4463–4470

    Google Scholar 

  3. Freter CE, Cossman J (1993) Angioimmunoblastic lymphadenopathy with dysproteinemia. Semin Oncol 20:627–635

    PubMed  CAS  Google Scholar 

  4. Bräuninger A, Spieker T, Willenbrock K, Gaulard P, Wacker HH, Rajewsky K, Hansmann ML, Kuppers R (2001) Survival and clonal expansion of mutating ‘forbidden’ (immunoglobulin receptor-deficient) Epstein–Barr virus-infected B cells in angioimmunoblastic T cell lymphoma. J Exp Med 194:927–940

    Article  PubMed  Google Scholar 

  5. Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch MR, Stein H (1992) Heterogeneous Epstein–Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80:1804–1812

    PubMed  CAS  Google Scholar 

  6. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ (1992) Detection and localization of Epstein–Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79:1789–1795

    PubMed  CAS  Google Scholar 

  7. Zettl A, Lee SS, Rudiger T, Starostik P, Marino M, Kirchner T, Ott M, Muller-Hermelink HK, Ott G (2002) Epstein–Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 117:368–379

    Article  PubMed  Google Scholar 

  8. Brearley RL, Chapman J, Cullen MH, Horton MA, Stansfeld AG, Waters AH (1979) Haematological features of angioimmunoblastic lymphadenopathy with dysproteinaemia. J Clin Pathol 32:356–360

    Article  PubMed  CAS  Google Scholar 

  9. Seehafer JR, Goldberg NC, Dicken CH, Su WP (1980) Cutaneous manifestations of angioimmunoblastic lymphadenopathy. Arch Dermatol 116:41–45

    Article  PubMed  CAS  Google Scholar 

  10. Pieters R, Martens J, Dequeker J (1982) Rheumatoid arthritis associated with bronchiolitis obliterans and immunoblastic sarcoma. Clin Rheumatol 1:35–40

    Article  PubMed  CAS  Google Scholar 

  11. Tobinai K, Minato K, Ohtsu T, Mukai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 72:1000–1006

    PubMed  CAS  Google Scholar 

  12. Siegert W, Nerl C, Agthe A, Engelhard M, Brittinger G, Tiemann M, Lennert K, Huhn D (1995) Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol 6:659–664

    PubMed  CAS  Google Scholar 

  13. Pautier P, Devidas A, Delmer A, Dombret H, Sutton L, Zini JM, Nedelec G, Molina T, Marolleau JP, Brice P (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545–552

    PubMed  CAS  Google Scholar 

  14. Ambepitiya GB (1989) Angioimmunoblastic lymphadenopathy associated with thyroid disease. J Clin Pathol 42:668–669

    Article  PubMed  CAS  Google Scholar 

  15. Hamidou MA, El Kouri D, Audrain M, Grolleau JY (2001) Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis 60:293–295

    Article  PubMed  CAS  Google Scholar 

  16. Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller AC (1987) Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 40:995–1015

    Article  PubMed  CAS  Google Scholar 

  17. Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC, Chuang SS, Cabeçadas J, Isaacson PG, Du MQ, Gaulard P, Dogan A (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlationand insights into natural history and disease progression. Am J Surg Pathol 31:1077–1088

    Article  PubMed  Google Scholar 

  18. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J, Kim DS (1998) Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 22:643–655

    Article  PubMed  CAS  Google Scholar 

  19. Attygalle A, Al Jehani R, Diss TC, Munson P, Liu H, Du MQ, Isaacson PG, Dogan A (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627–633

    Article  PubMed  CAS  Google Scholar 

  20. Dunleavy K, Wilson WH, Jaffe ES (2007) Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications. Curr Opin Hematol 14:348–353

    Article  PubMed  CAS  Google Scholar 

  21. Siegert W, Nerl C, Meuthen I, Zahn T, Brack N, Lennert K (1991) Huhn: recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. Leukemia 5:892–895

    PubMed  CAS  Google Scholar 

  22. Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Engelhard M, Kuse R, Tiemann M, Lennert K, Huhn D (1992) Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM ⁄ IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med 117:364–370

    PubMed  CAS  Google Scholar 

  23. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Brière J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, Berger F, Bouhabdallah R, Diebold J (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s lymphomas: Groupe d’Etude des Lymphomes de l’Adulte (GELA). Blood 92:76–82

    PubMed  CAS  Google Scholar 

  24. Iannitto E, Ferreri AJ, Minardi V, Tripodo C, Kreipe HH (2008) Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol 68(3):264–271

    Article  PubMed  Google Scholar 

  25. Pizzolo G, Stein H, Josimovic-Alasevic O, Vinante F, Zanotti R, Chilosi M, Feller AC, Diamantstein T (1990) Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms. Br J Haematol 75:485–488

    Article  PubMed  CAS  Google Scholar 

  26. Takeshita M, Sumiyoshi Y, Masuda Y, Ohshima K, Yoshida T, Kikuchi M, Muller H (1993) Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin- 6)-possessing cells in lymph nodes of malignant lymphoma. Pathol Res Pract 189:18–25

    Article  PubMed  CAS  Google Scholar 

  27. Foss HD, Anagnostopoulos I, Herbst H, Grebe M, Ziemann K, Hummel M, Stein H (1995) Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 85:2862–2869

    PubMed  CAS  Google Scholar 

  28. Ohshima KS, Suzumiya J, Kawasaki C, Kanda M, Kikuchi M (2000) Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 38:541–545

    Article  CAS  Google Scholar 

  29. Jones D, Fletcher CD, Pulford K, Shahsafaei A, Dorfman DM (1999) The T-cell activation markers CD30 and OX40 ⁄ CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Blood 93:3487–3493

    PubMed  CAS  Google Scholar 

  30. Jones D, O’Hara C, Kraus MD, Perez-Atayde AR, Shahsafaei A, Wu L, Dorfman DM (2000) Expression pattern of T-cellassociated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96:685–690

    PubMed  CAS  Google Scholar 

  31. Dorfman DM, Shahsafaei A (2002) CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas. Hum Pathol 33:330–334

    Article  PubMed  CAS  Google Scholar 

  32. Dogan A, Attygalle AD, Kyriakou C (2003) Angioimmunoblastic T-cell lymphoma. Br J Haematol 121(5):681–691

    Article  PubMed  Google Scholar 

  33. Pálóczi K, Surányi P, Nemes Z, Szegedi Gy (1986) A study of lymphocyte subsets in patients with angioimmunoblastic lymphadenopathy. 62(4): 615–618

  34. Pizzolo G, Vinante F, Agostini C, Zambello R, Trentin L, Masciarelli M, Chilosi M, Benedetti F, Dazzi F, Todeschini G (1987) Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer 60:2412–2418

    Article  PubMed  CAS  Google Scholar 

  35. Willenbrock K, Bräuninger A, Hansmann ML (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 138(6):733–739

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by research grant of ETT 200/2009.

Author information

Authors and Affiliations

  1. 3rd Department of Internal Medicine, University of Debrecen, Medical and Health Science Center, Móricz Zs. krt. 22, 4032, Debrecen, Hungary

    Edit Páyer, Zsófia Miltényi, Zsófia Simon & Árpád Illés

  2. Scanomed Ltd, Nagyerdei krt. 98, Debrecen, 4032, Hungary

    Lajos Szabados

  3. University of Debrecen, Medical and Health Science Center, Institute of Pathology, Nagyerdei krt. 98, Debrecen, 4032, Hungary

    Katalin Hegyi & Gábor Méhes

Authors
  1. Edit Páyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zsófia Miltényi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zsófia Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lajos Szabados
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katalin Hegyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gábor Méhes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Árpád Illés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edit Páyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Páyer, E., Miltényi, Z., Simon, Z. et al. Uncommon Late Relapse of Angioimmunoblastic T-Cell Lymphoma after 16-Year Remission Period. Pathol. Oncol. Res. 18, 737–741 (2012). https://doi.org/10.1007/s12253-011-9475-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9475-7

Keywords

Search

Navigation